Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Superior outcome from frontline cord blood transfusion combined HLA-full-matched unrelated donor hematopoietic stem cell transplantation for aplastic anemia

Xinru Jia, Tonglin Hu, Chuanao Xin, Qi Liu, Yingying Shen, Yaonan Hong, Shan Liu, Zexing Sun, Rudan Zheng, Xiawan Yang, Wenbin Liu, Qinghong Yu, Jianping Shen, Shengyun Lin, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2025) 146 (Supplement 1): 2512.

https://doi.org/10.1182/blood-2025-2512

Published: 2025

Journal Articles

Outcomes of haploidentical transplantation with umbilical cord blood co-infusion in aplastic anemia: Clinical and single-cell insights

Yu Zhang, Qijia Zheng, Nanxi Dong, Linlin Huang, Xianfu Sheng, Wenbin Liu, Dijiong Wu, Baodong Ye

Blood (2025) 146 (Supplement 1): 7777.

https://doi.org/10.1182/blood-2025-7777

Published: 2025

Journal Articles

New drug targets for acute myeloid leukemia identified through a comprehensive analysis of the plasma protein

Yaonan Hong, Shiyue Wu, Shun He, Qi Liu, Yingying Shen, Xiawan Yang, Peicheng Wang, Baodong Ye, Keding Shao, Ya-Huei Kuo, Dijiong Wu

Blood (2025) 146 (Supplement 1): 1695.

https://doi.org/10.1182/blood-2025-1695

Published: 2025

Journal Articles

Poor prognosis of immunosuppressive therapy in patients with bone marrow failure-related germline mutations combined with BCOR/L1 Mutations

Nanxi Dong, Jingjing Liu, Yingying Shen, Xinru Jia, Rudan Zheng, Peicheng Wang, Qiuqin Cheng, Yu Zhang, Bo Wang, Ningning Zhu, Zhengwei Tan, Dijiong Wu, Baodong Ye

Blood (2025) 146 (Supplement 1): 6718.

https://doi.org/10.1182/blood-2025-6718

Published: 2025

Journal Articles

Efficacy and safety of romiplostim N01 in cancer treatment–induced thrombocytopenia: Results from a phase II off-label study in China

Yu Zhang, Qijia Zheng, Nanxi Dong, Linlin Huang, Hangping Ge, Xianfu Sheng, Jingjing Xiang, Wenbin Liu, Dijiong Wu, Jianping Shen, Baodong Ye

Blood (2025) 146 (Supplement 1): 4806.

https://doi.org/10.1182/blood-2025-4806

Published: 2025

Journal Articles

Trial in progress: Romiplostim N01 combined with immunosuppressive therapy in patients diagnosed with non-severe aplastic anemia, a Phase II study

Yun Zhang, Bo Wang, Dijiong Wu, Shu Deng, Jianping Shen, Qinghong Yu, Wenbin Liu, Tonglin Hu, Wenbin Qian, Dan Chen, Weiying Feng, Baodong Ye

Blood (2025) 146 (Supplement 1): 6735.

https://doi.org/10.1182/blood-2025-6735

Published: 2025

Journal Articles

High complicated incidence of Gilbert's syndrome in patients with thalassemia: Deserve earlier identification and less oversight

Tianyi Lai, Yaonan Hong, Peicheng Wang, Qi Liu, Yingying Shen, Wanzhi Jiang, Xiawan Yang, Yiping Shen, Shan Liu, Dijiong Wu

Blood (2025) 146 (Supplement 1): 2913.

https://doi.org/10.1182/blood-2025-2913

Published: 2025

Journal Articles

Romiplostim N01 enhances platelet engraftment in ASCT using non-cryopreserved pbscs for plasma cell neoplasms: A single-center phase II study in China

Xianfu Sheng, Huijin Hu, Yuechao Zhao, Ni Zhu, Yun Zhang, Yingying Shen, Jingjing Xiang, Bo Wang, Dijiong Wu, Yu Zhang, Baodong Ye

Blood (2025) 146 (Supplement 1): 5972.

https://doi.org/10.1182/blood-2025-5972

Published: 2025

Journal Articles

Serum cholesterol levels define an inverted u-shaped relationship with PBSC mobilization and immune balance in healthy donors

Ningning Zhu, Jingjing Liu, Nanxi Dong, Huijin Hu, Baodong Ye, Dijiong Wu

Blood (2025) 146 (Supplement 1): 7613.

https://doi.org/10.1182/blood-2025-7613

Published: 2025

Journal Articles

Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial

Blood (2024) 144 (Supplement 1): 3949.

https://doi.org/10.1182/blood-2024-201872

Published: 2024

Journal Articles

A Prognostic Model Guiding Treatment Switch for 5-Year Deep Molecular Response in Chronic Myeloid Leukemia Patients Receiving Initial Imatinib: An Extensive, Multi-Center, Retrospective Study

Tian Zeng, Xiudi Yang, Yi Wang, Dijiong Wu, Weiying Feng, Ying Lu, Huafeng Wang, Jian Huang

Blood (2024) 144 (Supplement 1): 1770.

https://doi.org/10.1182/blood-2024-204525

Published: 2024

Journal Articles

A Nomogram for Predicting T315I-Free Survival in Chronic Phase Chronic Myeloid Leukemia Patients: A Multi-Center Retrospective Study

Shiwei Hu, Xiudi Yang, Dijiong Wu, Yi Wang, Xiaoqiong Zhu, Weiying Feng, Huafeng Wang, Jian Huang

Blood (2024) 144 (Supplement 1): 1769.

https://doi.org/10.1182/blood-2024-203703

Published: 2024

Journal Articles

Matrine Synergistically Promotes Non-Toxic-Dose RLS3 Induced Ferroptosis in Acute Myeloid Leukemic Cells with MLL Translocation

Yaonan Hong, Fanhua Yu, Man Li, Jingjie Dong, Yingying Shen, Xiawan Yang, Keding Shao, Qi Liu, Peicheng Wang, Yuhong Zhou, Yiping Shen, Dijiong Wu

Blood (2024) 144 (Supplement 1): 5775.

https://doi.org/10.1182/blood-2024-198760

Published: 2024

Journal Articles

Integrated Stress Response Activation Induced By Usnic Acid Alleviates BCL-2 Inhibitor ABT-199 Resistance in Acute Myeloid Leukemia

Man Li, Jingjie Dong, Yaonan Hong, Li Jin, Chengtao Sun, Qi Liu, Liqin Li, Xiaoxiao Han, Shengqian Deng, Yue Feng, Yiping Shen, Guoyin Kai, Dijiong Wu

Blood (2024) 144 (Supplement 1): 4158.

https://doi.org/10.1182/blood-2024-198752

Published: 2024

Journal Articles

Identification and Validation of Ferroptosis-Related Genes As Novel Prognosis Prediction Panel for Acute Myeloid Leukemia

Yaonan Hong, Tianyi Lai, Huijin Hu, Hangping Ge, Yuechao Zhao, Yingying Shen, Tonglin Hu, Qi Liu, Zhenchao Zhuang, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2023) 142 (Supplement 1): 6040.

https://doi.org/10.1182/blood-2023-184396

Published: 2023

Journal Articles

Identification of Anti-HLA-C Autoantibody As Risk Factor for Primary Platelet Transfusion Refractoriness in Patients with Hematologic Disorders

Xunhua Li, Tonglin Hu, Qi Liu, Jingjie Dong, Junfeng Guo, Yaonan Hong, Yingying Shen, Yiping Shen, Jianping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2023) 142 (Supplement 1): 4035.

https://doi.org/10.1182/blood-2023-186675

Published: 2023

Journal Articles

New Aplastic Anemia Preconditioned with Fludarabine, Thiotepa, Cyclophosphamide, and Anti-Thymocyte Globulin

Wenbin Liu, Zhengwei Tan, Sr., Yuechao Zhao, Huijin Hu, Dijiong Wu, Baodong Ye

Blood (2023) 142 (Supplement 1): 2160.

https://doi.org/10.1182/blood-2023-179680

Published: 2023

Journal Articles

Differences between Peripheral and Bone Marrow Lipidomics in Patients with Severe Aplastic Anemia and Its Finding in Predicting the Early Immunosuppressive Therapy Response

Zexing Sun, Yilei Hong, Wanzhi Jiang, Yingying Shen, Huijin Hu, Tonglin Hu, Qi Liu, Zhenchao Zhuang, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2023) 142 (Supplement 1): 2718.

https://doi.org/10.1182/blood-2023-184631

Published: 2023

Journal Articles

Apolipoprotein-a Is a Potential Prognosis Biomarker for Severe Aplastic Anemia Patients Treated with ATG-Based Immunosuppressive Therapy: A Single-Center Retrospective Study

Qi Liu, Huijie Dong, Yingying Shen, Yuzhu Li, Yilei Hong, Ying Chen, Shan Liu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Shengyun Lin, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2022) 140 (Supplement 1): 11043–11044.

https://doi.org/10.1182/blood-2022-158733

Published: 2022

Journal Articles

Synergistic Effect of Low-Dose Cyclosporine a on Eltrombopag (EPAG) in the Management of Prior Epag and Multiline Failed Immune Thrombocytopenia Patients: A Single-Center, Self-Control Study

Yilei Hong, Yingying Shen, Qi Liu, Jingjie Dong, Jingjing Xiang, Wenbin Liu, Yiping Shen, Liqiang Wu, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2022) 140 (Supplement 1): 8386–8387.

https://doi.org/10.1182/blood-2022-159032

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Superior outcome from frontline cord blood transfusion combined HLA-full-matched unrelated donor hematopoietic stem cell transplantation for aplastic anemia

Outcomes of haploidentical transplantation with umbilical cord blood co-infusion in aplastic anemia: Clinical and single-cell insights

New drug targets for acute myeloid leukemia identified through a comprehensive analysis of the plasma protein

Poor prognosis of immunosuppressive therapy in patients with bone marrow failure-related germline mutations combined with BCOR/L1 Mutations

Efficacy and safety of romiplostim N01 in cancer treatment–induced thrombocytopenia: Results from a phase II off-label study in China

Trial in progress: Romiplostim N01 combined with immunosuppressive therapy in patients diagnosed with non-severe aplastic anemia, a Phase II study

High complicated incidence of Gilbert's syndrome in patients with thalassemia: Deserve earlier identification and less oversight

Romiplostim N01 enhances platelet engraftment in ASCT using non-cryopreserved pbscs for plasma cell neoplasms: A single-center phase II study in China

Serum cholesterol levels define an inverted u-shaped relationship with PBSC mobilization and immune balance in healthy donors

Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial

A Prognostic Model Guiding Treatment Switch for 5-Year Deep Molecular Response in Chronic Myeloid Leukemia Patients Receiving Initial Imatinib: An Extensive, Multi-Center, Retrospective Study

A Nomogram for Predicting T315I-Free Survival in Chronic Phase Chronic Myeloid Leukemia Patients: A Multi-Center Retrospective Study

Matrine Synergistically Promotes Non-Toxic-Dose RLS3 Induced Ferroptosis in Acute Myeloid Leukemic Cells with MLL Translocation

Integrated Stress Response Activation Induced By Usnic Acid Alleviates BCL-2 Inhibitor ABT-199 Resistance in Acute Myeloid Leukemia

Identification and Validation of Ferroptosis-Related Genes As Novel Prognosis Prediction Panel for Acute Myeloid Leukemia

Identification of Anti-HLA-C Autoantibody As Risk Factor for Primary Platelet Transfusion Refractoriness in Patients with Hematologic Disorders

New Aplastic Anemia Preconditioned with Fludarabine, Thiotepa, Cyclophosphamide, and Anti-Thymocyte Globulin

Differences between Peripheral and Bone Marrow Lipidomics in Patients with Severe Aplastic Anemia and Its Finding in Predicting the Early Immunosuppressive Therapy Response

Apolipoprotein-a Is a Potential Prognosis Biomarker for Severe Aplastic Anemia Patients Treated with ATG-Based Immunosuppressive Therapy: A Single-Center Retrospective Study

Synergistic Effect of Low-Dose Cyclosporine a on Eltrombopag (EPAG) in the Management of Prior Epag and Multiline Failed Immune Thrombocytopenia Patients: A Single-Center, Self-Control Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only